Table 1. Sequences of primers used in this study.

Gene	Sequence
STAT3	Forward: 5′-AGCAAGAGGGGATTTCACAAT-3′
	Reverse: 5′-GGTCGTTCTACTGGGCTGATT-3′
NF-κB	Forward: 5′-GTCAGTGAGAAGCAAGTCGA-3′
	Reverse: 5′-ATGTTCTTCTCTGTGACCCA-3′
MAT3	Forward: 5′-GCTGGCTGAGTACCAGTA-3′
	Reverse: 5′-CTTCTTCAAGGACCGGTCA-3′
E-cadherin	Forward: 5′-GTGCTGACGCTAACTGACC-3′
	Reverse: 5′-GCACCCATGGCAGAAGGAGGAG-3′
Bcl-2	Forward: 5′-CTCAGCCAGCCAGTGACATA-3′
	Reverse: 5′-CCGTGCTCCAGATACAT-3′
Bcl-xl	Forward: 5′-AGAGTGGACCACACTGCGC-3′
	Reverse: 5′-ACATCCCAACGGTCATCGTA-3′
P53	Forward: 5′-GAAGATGGAGAGATGG-3′
	Reverse: 5′-GGAGGGGATCAGTATATACA-3′
Apaf1	Forward: 5′-TTGGAGGGAACAGACGAG-3′
	Reverse: 5′?CTGTGAGATCACTGGCTTTG-3′
CDK1	Forward: 5′-CCGGAGAGGAGACTTCACAG-3′
	Reverse: 5′-ACAGTGCATCATCGCTGTTC-3′
Cyclin-B1	Forward: 5′-TAAGGAAGCCTGGAGCACAG-3′
	Reverse: 5′-GAAAGCATCCAGCAATAGGC-3′
P27	Forward: 5′-GCCTCAGCCTCCCGAGTAG-3′
	Reverse: 5′-CATGGTGAAACCCCGTCTCTA-3′
MDR1	Forward: 5′-TTAAATGTATACCCAAAGACAA-3′
	Reverse: 5′-GGGCAGAATCTTTCCACCA-3′
LRP	Forward: 5′-CTTCAATTGTATTCAGGATGG-3′
	Reverse: 5′-CGAATGGGTGTTTTCACATATG-3′
TS	Forward: 5′-CCGTTGTTGTAGGACTAATGAA-3′
	Reverse: 5′-CACCCTCAATATTTGGAA-3′
β-actin	Forward: 5′-AGCCTTCTCCATGGTCGTGA-3′
	Reverse: 5′-CGGAGTCAACGGATTTGGTC-3′